Data Foundry

Drug recalls 2019

Cetirizine Oral Solution 1 mg/mL — Class II drug recall D-1408-2019

Terminated recall by P & L Developments, LLC, reported 2019-06-26, distributed nationwide. cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the

Recall numberD-1408-2019
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmP & L Developments, LLC, Westbury, NY, United States
Recall initiated2019-06-05
Classified2019-06-20
Reported by FDA2019-06-26
Terminated2020-09-09
DistributedNationwide (US)
Quantity17,664 bottles
Reason classescgmp
Pathogensburkholderia
UPC / GTIN / UDI-DI00635515992474
NDC63868-0430-04
Lot numbers10/19, 12/19, 2/20, 8/20, C04866, C09863, F01267, F12609, F25327

Product

Cetirizine Oral Solution 1 mg/mL, Children's Allergy, Antihistamine, Dye Free, Grape Flavor, 4 FL. oz. Bottle, Distributed by C.D.M.A. Inc., Novi, MI 48376, Quality Choice, NDC 63868-430-04, UPC 635515992474.

Reason for recall

cGMP Deviations: Firm was notified by their supplier of Cetirizine HCL Oral Solution, USP, 1mg/mL, 4oz, of the voluntary recall that they have initiated due to potential contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1408-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.